Komori
ImageONE (2667) · RiskWorsenedLatest Occurring Fact (2026-06-29): "Mitigated"

Risks of Counterparty Claims and Additional Costs Resulting from Transaction Cancellations

First written in FY2024-Q1. 3 of 6 entries say "Worsened", first in FY2024-Q2. Latest entry: 2026-06-29.

6entries
3years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2024-Q2 – 2026-05-142024: 220242025: 220252026: 22026
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025-H1WorsenedAnnual report

    「In connection with transactions related to the environmentally friendly business of reusing and renting refurbished EV batteries as portal batteries for business use, the Company has been sued by 株式会社ワンダーランド and 5 other companies as described below. The Company’s results may be affected depending on developments in the litigation.」

    The litigation expanded from the previous 2 cases. Claims totaling ¥617.637 million were disclosed for the 6 companies ワンダーランド, プロスパーアセット, ケイ・アイ・シー, WEBLA, 日本粉末薬品 and 城北ヤクルト販売. In addition, before the filing date, Y・Aホールディングス filed a lawsuit seeking ¥62.315 million.
  2. FY2024MaterialisedAnnual report

    「In connection with transactions related to the environmentally friendly business of reusing and renting refurbished EV batteries as portal batteries for business use, the Company has been sued by 株式会社ワンダーランド and 株式会社プロスパーアセット as described below. The Company’s results may be affected depending on developments in the litigation.」

    The possibility of claims from counterparties described in the prior filing materialized as lawsuits filed by ワンダーランド and プロスパーアセット. The claim amounts disclosed were ¥20.68 million and ¥16.2228 million, respectively.
  3. FY2024-Q2WorsenedAnnual report

    「The balances related to the relevant transactions included in “suspense payments” under current assets and “suspense receipts” under current liabilities amounted to ¥445.969 million and ¥623.684 million, respectively. The Group has not, as of the present time, received a demand from the counterparty for payment of an amount equivalent to the consideration received by the Group in connection with the relevant operations, but may receive such a demand in the future.」

    The suspense payment and suspense receipt balances related to the cancelled transactions increased from the end of the previous fiscal year, and the possibility of additional costs exceeding the difference between suspense receipts and suspense payments continues to be disclosed. No claim or litigation had been received as of the present time.
  4. FY2024-Q1First statedAnnual report

    「The Group has not, as of the present time, received a demand from the counterparty for payment of an amount equivalent to the consideration received by the Group in connection with the relevant operations, but may receive such a demand in the future. The Group plans to discuss the matter with the counterparty and others based on the findings in the third-party committee’s investigation report. Depending on the outcome of future discussions, the Group’s results of operations may be affected if it incurs costs exceeding the difference between the suspense receipts and suspense payments described above, although it is difficult to reasonably estimate the amount of such impact at this time.」

    In connection with the cancellation of sales and cost of sales based on the third-party committee investigation, the Company disclosed a new contingent-liability risk involving potential payment claims from counterparties and additional costs exceeding the difference between suspense payments and suspense receipts. The balances of suspense payments and suspense receipts were also disclosed at ¥375.498 million and ¥549.808 million, respectively, but no claim or litigation had arisen as of the present time.
Moved together

"PACS: A Mature Market, with Further Adoption Potential for Cloud-Based Electronic Medical Records" moved the same way as this thread, in the same document, in 4 of its 6 moves.

433333★123456
  1. ★This thread
  2. 1PACS: A Mature Market, with Further Adoption Potential for Cloud-Based Electronic Medical Records4×
  3. 2Enhancing product competitiveness and profit margins in the medical imaging business3×
  4. 3Higher revenue and narrower operating, ordinary and net losses3×
  5. 4Return to Positive Operating Cash Flow3×
  6. 5Sales of PCR testing reagents and antibody test kits3×
  7. 6Launch of the Medical Supplies Business3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for ImageONE yet. It last moved in the Occurring Fact of 2026-06-29: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks of Counterparty Claims and Additional Costs Resulting from Transaction Cancellations | ImageONE Co.,Ltd. (2667) | Komori